BANK OF MONTREAL /CAN/ - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$0
-100.0%
19
-97.3%
0.00%
Q1 2019$1,000
-50.0%
700
-50.9%
0.00%
Q4 2018$2,000
-75.0%
1,426
-50.9%
0.00%
Q3 2018$8,000
+60.0%
2,902
+94.0%
0.00%
Q2 2018$5,0000.0%1,496
-7.5%
0.00%
Q1 2018$5,000
-28.6%
1,618
+36.3%
0.00%
Q4 2017$7,000
+40.0%
1,187
+65.3%
0.00%
Q3 2017$5,0000.0%718
+2.6%
0.00%
Q2 2017$5,000
-16.7%
7000.0%0.00%
Q1 2017$6,000
-94.2%
700
-97.2%
0.00%
Q4 2016$103,000
+1187.5%
24,689
+1024.3%
0.00%
Q3 2016$8,000
+166.7%
2,196
+211.9%
0.00%
Q2 2016$3,000
+50.0%
704
+87.7%
0.00%
Q1 2016$2,000
-97.6%
375
-95.5%
0.00%
Q4 2015$84,000
-95.2%
8,362
-96.5%
0.00%
-100.0%
Q3 2015$1,764,000
-78.9%
236,378
+33.8%
0.00%
-80.0%
Q2 2015$8,378,000
+29.0%
176,607
-0.4%
0.01%
+25.0%
Q1 2015$6,495,000
+129800.0%
177,250
+49136.1%
0.01%
Q2 2014$5,0000.0%360
-44.6%
0.00%
Q2 2013$5,0006500.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2018
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 317,900$11,647,0004.28%
Opaleye Management Inc. 175,000$6,412,0002.98%
Graticule Asia Macro Advisors LLC 413,200$15,139,0002.02%
BB BIOTECH AG 1,477,114$54,121,0001.61%
Iguana Healthcare Management, LLC 75,000$2,748,0001.16%
Granite Point Capital Management, L.P. 79,250$2,904,0001.06%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 458,202$16,788,0000.89%
Ghost Tree Capital, LLC 130,000$4,764,0000.86%
SECTORAL ASSET MANAGEMENT INC 605,393$22,182,0000.84%
HealthCor Management, L.P. 467,200$17,118,0000.82%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders